FGL1 and type 2 diabetes mellitus: miRBase analysis showed that identified FGL1 3′UTR mutations may affect miRNA binding sites previously reported as correlated with obesity, including those involved in the insulin signaling pathway, maturity-onset diabetes of the young, type II diabetes mellitus, and adipocytokine signaling pathway (Table S3).